Good news, mostly -UPDATED with video
The latest round of OAT, stool and conventional “HIV” surrogate test markers are in, and the news is mostly good. Regardless of which angle one looks at these laboratory test results from, there is evidence to support an evolving thesis that a multi-faceted approach to immune dysfunction might be as efficacious as the current pharmaceutical-based guidelines for treating “HIV/AIDS”, minus the worst of the adverse effects. The not-so-good news is that the continuation of this seven year long experience (experiment?) is being jeopardized by the lack of financial resources. There, I said it, and I won’t mention it again until the end of this post.
